1. Home
  2. IOVA vs CNL Comparison

IOVA vs CNL Comparison

Compare IOVA & CNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • CNL
  • Stock Information
  • Founded
  • IOVA 2007
  • CNL 2018
  • Country
  • IOVA United States
  • CNL Canada
  • Employees
  • IOVA N/A
  • CNL N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • CNL
  • Sector
  • IOVA Health Care
  • CNL
  • Exchange
  • IOVA Nasdaq
  • CNL NYSE
  • Market Cap
  • IOVA 975.1M
  • CNL 859.5M
  • IPO Year
  • IOVA N/A
  • CNL N/A
  • Fundamental
  • Price
  • IOVA $2.68
  • CNL $9.26
  • Analyst Decision
  • IOVA Buy
  • CNL Strong Buy
  • Analyst Count
  • IOVA 10
  • CNL 1
  • Target Price
  • IOVA $12.22
  • CNL $8.00
  • AVG Volume (30 Days)
  • IOVA 26.0M
  • CNL 68.1K
  • Earning Date
  • IOVA 08-07-2025
  • CNL 01-01-0001
  • Dividend Yield
  • IOVA N/A
  • CNL N/A
  • EPS Growth
  • IOVA N/A
  • CNL N/A
  • EPS
  • IOVA N/A
  • CNL N/A
  • Revenue
  • IOVA $212,679,000.00
  • CNL N/A
  • Revenue This Year
  • IOVA $86.62
  • CNL N/A
  • Revenue Next Year
  • IOVA $69.13
  • CNL N/A
  • P/E Ratio
  • IOVA N/A
  • CNL N/A
  • Revenue Growth
  • IOVA 11070.12
  • CNL N/A
  • 52 Week Low
  • IOVA $1.64
  • CNL $2.43
  • 52 Week High
  • IOVA $12.51
  • CNL $12.04
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 53.63
  • CNL N/A
  • Support Level
  • IOVA $1.70
  • CNL N/A
  • Resistance Level
  • IOVA $4.33
  • CNL N/A
  • Average True Range (ATR)
  • IOVA 0.40
  • CNL 0.00
  • MACD
  • IOVA -0.01
  • CNL 0.00
  • Stochastic Oscillator
  • IOVA 37.26
  • CNL 0.00

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About CNL COLLECTIVE MINING LTD

Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia. The company is rapidly advancing exploration on large-scale copper-gold-molybdenum porphyry targets in the mining-friendly department of Caldas in Colombia. Drilling is underway at the Guayabales project which is strategically located contiguous to the Marmato deposit, with initial assay results ongoing.

Share on Social Networks: